Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells

References

• Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. 2009. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 61:428–37.
   PubMed Web of Science ®Google Scholar
• Bramanti E, Benedetti E. 1996. Determination of the secondary structure of isomeric forms of human serum albumin by a particular frequency deconvolution procedure applied to Fourier transform IR analysis. Biopolymers 38:639–53.
   PubMed Web of Science ®Google Scholar
• Cheng X, Tian X, Wu A, Li J, Tian J, Chong Y, et al. 2015. Protein corona influences cellular uptake of gold nanoparticles by phagocytic and nonphagocytic cells in a size-dependent manner. ACS Appl Mater Interfaces 7:20568–75.
   PubMed Web of Science ®Google Scholar
• Cho EC, Xie J, Wurm PA, Xia Y. 2009. Understanding the role of surface charges in cellular adsorption versus internalization by selectively removing gold nanoparticles on the cell surface with a I2/KI etchant. Nano Lett 9:1080–4.
   PubMed Web of Science ®Google Scholar
• Choi K, Riviere JE, Monteiro-Riviere NA. 2017. Protein corona modulation of hepatocyte uptake and molecular mechanisms of gold nanoparticle toxicity. Nanotoxicology 11:64–75.
   PubMed Web of Science ®Google Scholar
• Davis ME. 2009. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 6:659–68.
   PubMed Web of Science ®Google Scholar
• Deng ZJ, Liang M, Monteiro M, Toth I, Minchin RF. 2011. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat Nanotechnol 6:39–44.
   PubMed Web of Science ®Google Scholar
• Deng ZJ, Liang M, Toth I, Monteiro M, Minchin RF. 2013. Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses. Nanotoxicology 7:314–22.
   PubMed Web of Science ®Google Scholar
• Docter D, Westmeier D, Markiewicz M, Stolte S, Knauer SK, Stauber RH. 2015. The nanoparticle biomolecule corona: lessons learned – challenge accepted? Chem Soc Rev 44:6094–121.
   PubMed Web of Science ®Google Scholar
• Dreaden EC, Austin LA, Mackey MA, El-Sayed MA. 2012. Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv 3:457–78.
   PubMedGoogle Scholar
• Freese C, Gibson MI, Klok HA, Unger RE, Kirkpatrick CJ. 2012. Size- and coating-dependent uptake of polymer-coated gold nanoparticles in primary human dermal microvascular endothelial cells. Biomacromolecules 13:1533–43.
   PubMed Web of Science ®Google Scholar
• Hubbell JA, Langer R. 2013. Translating materials design to the clinic. Nat Mater 12:963–6.
   PubMed Web of Science ®Google Scholar
• Karmali PP, Simberg D. 2011. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv 8:343–57.
   PubMed Web of Science ®Google Scholar
• Klingberg H, Oddershede LB, Loeschner K, Larsen EH, Loft S, Moller P. 2015. Uptake of gold nanoparticles in primary human endothelial cells. Toxicol Res 4:655–66.
   Web of Science ®Google Scholar
• Klingberg H, Loft S, Oddershede LB, Moller P. 2015. The influence of flow, shear stress and adhesion molecule targeting on gold nanoparticle uptake in human endothelial cells. Nanoscale 7:11409–19.
   PubMed Web of Science ®Google Scholar
• Lacerda SH, Park JJ, Meuse C, Pristinski D, Becker ML, Karim A, Douglas JF. 2010. Interaction of gold nanoparticles with common human blood proteins. ACS Nano 4:365–79.
   PubMed Web of Science ®Google Scholar
• Li Y, Monteiro-Riviere NA. 2016. Mechanisms of cell uptake, inflammatory potential and protein corona effects with gold nanoparticles. Nanomedicine 11:3185–203.
   PubMed Web of Science ®Google Scholar
• Loo C, Lin A, Hirsch L, Lee MH, Barton J, Halas N, et al. 2004. Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat 3:33–40.
   PubMed Web of Science ®Google Scholar
• Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 105:14265–70.
   PubMed Web of Science ®Google Scholar
• Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA. 2007. The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci 134-135:167–74.
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. 2011. Protein-nanoparticle interactions: opportunities and challenges. Chem Rev 111:5610–37.
   PubMed Web of Science ®Google Scholar
• Mirsadeghi S, Dinarvand R, Ghahremani MH, Hormozi-Nezhad MR, Mahmoudi Z, Hajipour MJ, et al. 2015. Protein corona composition of gold nanoparticles/nanorods affects amyloid beta fibrillation process. Nanoscale 7:5004–13.
   PubMed Web of Science ®Google Scholar
• Mirshafiee V, Kim R, Mahmoudi M, Kraft ML. 2016. The importance of selecting a proper biological milieu for protein corona analysis in vitro: human plasma versus human serum. Int J Biochem Cell Biol 75:188–95.
   PubMed Web of Science ®Google Scholar
• Monopoli MP, Aberg C, Salvati A, Dawson KA. 2012. Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol 7:779–86.
   PubMed Web of Science ®Google Scholar
• Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA. 2011. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 133:2525–34.
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA, Inman AO, Zhang LW. 2009. Limitations and relative utility of screening assays to assess engineered nanoparticle toxicity in a human cell line. Toxicol Appl Pharmacol 234:222–35.
   PubMed Web of Science ®Google Scholar
• Monteiro-Riviere NA, Samberg ME, Oldenburg SJ, Riviere JE. 2013. Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett 220:286–93.
   PubMed Web of Science ®Google Scholar
• Mosesson MW. 2005. Fibrinogen and fibrin structure and functions. J Thromb Haemost 3:1894–904.
   PubMed Web of Science ®Google Scholar
• Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater 8:543–57.
   PubMed Web of Science ®Google Scholar
• Nesvizhskii AI, Keller A, Kolker E, Aebersold R. 2003. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75:4646–58.
   PubMed Web of Science ®Google Scholar
• Pearson RM, Hsu HJ, Bugno J, Hong S. 2014. Understanding nano-bio interactions to improve nanocarriers for drug delivery. MRS Bull 39:227–37.
   Web of Science ®Google Scholar
• Pearson RM, Juettner VV, Hong S. 2014. Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery. Front Chem 2:108.
   PubMed Web of Science ®Google Scholar
• Podila R, Chen R, Ke PC, Brown JM, Rao AM. 2012. Effects of surface functional groups on the formation of nanoparticle-protein corona. Appl Phys Lett 101:263701.
   PubMed Web of Science ®Google Scholar
• Rahman M, Laurent S, Tawil N, Yahia LH, Mahmoudi M. 2013. Nanoparticle and protein corona. In: Rahman M, Laurent S, Tawil N, Yahia LH, Mahmoudi M, eds. Protein-nanoparticle interactions: the bio-nano interface. Berlin, Heidelberg: Springer Berlin Heidelberg, 21–44.
   Google Scholar
• Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H. 2009. Nanomedicine-challenge and perspectives. Angew Chem Int Ed Engl 48:872–97.
   PubMed Web of Science ®Google Scholar
• Ritz S, Schottler S, Kotman N, Baier G, Musyanovych A, Kuharev J, et al. 2015. Protein corona of nanoparticles: distinct proteins regulate the cellular uptake. Biomacromolecules 16:1311–21.
   PubMed Web of Science ®Google Scholar
• Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. 2010. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ Health Perspect 118:407–13.
   PubMed Web of Science ®Google Scholar
• Sasidharan A, Chandran P, Monteiro-Riviere NA. 2016. Biocorona bound gold nanoparticles augment their hematocompatibility irrespective of size or surface charge. ACS Biomater Sci Eng 2:1608–18.
   Web of Science ®Google Scholar
• Sasidharan A, Monteiro-Riviere NA. 2015. Biomedical applications of gold nanomaterials: opportunities and challenges. Wiley Interdiscip Rev Nanomed Nanobiotechnol 7:779.
   PubMed Web of Science ®Google Scholar
• Sasidharan A, Riviere JE, Monteiro-Riviere NA. 2015. Gold and silver nanoparticle interactions with human proteins: impact and implications in biocorona formation. J Mater Chem B 3:2075–82.
   PubMed Web of Science ®Google Scholar
• Seigneuric R, Markey L, Nuyten DS, Dubernet C, Evelo CT, Finot E, Garrido C. 2010. From nanotechnology to nanomedicine: applications to cancer research. Curr Mol Med 10:640–52.
   PubMed Web of Science ®Google Scholar
• Sengupta S, Kulkarni A. 2013. Design principles for clinical efficacy of cancer nanomedicine: a look into the basics. ACS Nano 7:2878–82.
   PubMed Web of Science ®Google Scholar
• Stayton I, Winiarz J, Shannon K, Ma Y. 2009. Study of uptake and loss of silica nanoparticles in living human lung epithelial cells at single cell level. Anal Bioanal Chem 394:1595–608.
   PubMed Web of Science ®Google Scholar
• Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, et al. 2013. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 8:772–81.
   PubMed Web of Science ®Google Scholar
• van der Meel R, Vehmeijer LJ, Kok RJ, Storm G, van Gaal EV. 2013. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status. Adv Drug Deliv Rev 65:1284–98.
   PubMed Web of Science ®Google Scholar
• Vroman L, Adams AL, Fischer GC, Munoz PC. 1980. Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces. Blood 55:156–9.
   PubMed Web of Science ®Google Scholar
• Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. 2010. What the cell “sees” in bionanoscience. J Am Chem Soc 132:5761–8.
   PubMed Web of Science ®Google Scholar
• Walkey CD, Chan WC. 2012. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41:2780–99.
   PubMed Web of Science ®Google Scholar
• Walkey CD, Olsen JB, Guo H, Emili A, Chan WC. 2012. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134:2139–47.
   PubMed Web of Science ®Google Scholar
• Xia X, Xia Y. 2014. Gold nanocages as multifunctional materials for nanomedicine. Front Phys 9:378–84.
   Web of Science ®Google Scholar
• Xia XR, Monteiro-Riviere NA, Riviere JE. 2010. An index for characterization of nanomaterials in biological systems. Nat Nanotechnol 5:671–5.
   PubMed Web of Science ®Google Scholar
• Zuo L, Wei W, Morris M, Wei J, Gorbounov M, Wei C. 2007. New technology and clinical applications of nanomedicine. Med Clin North Am 91:845–62.
   PubMed Web of Science ®Google Scholar